Pharmaceutical Executive-03-19-2008

Pharmaceutical Executive

A Slow Year for Pharma–with a Few Exceptions

March 19, 2008

News Analysis

0

0

The US pharma market grew just 3.8 percent last year, according to IMS Health. The big loser: lipid regulators. The winners: Biologic response modulators and monoclonal antibodies.